Michael T. Murray
Impact in
- Pharmacology top 0.05%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Biochemistry top 0.5%
- Eicosanoids and Hypertension Pharmacology
Papers in
- Pharmacology 110
- Pharmacogenetics and Drug Metabolism 107
- Drug-Induced Hepatotoxicity and Protection 14
- Inflammatory mediators and NSAID effects 13
- Biochemistry 57
- Eicosanoids and Hypertension Pharmacology 51
- Co-authors
- Geoffrey C. FarrellGordon F. ReidyFanfan ZhouNenad PetrovićAlison ButlerWerner W. FrankeTristan RawlingJoseph E. Pizzorno
- Journals
- Biochemical Pharmacology (29 papers)British Journal of Pharmacology (14 papers)Journal of Pharmacology and Experimental Therapeutics (10 papers)Molecular Pharmacology (7 papers)Xenobiotica (6 papers)
- Partner nations
- AustraliaUnited StatesChina
In The Last Decade
Michael T. Murray
239 papers receiving 6.0k citations
Peers
Comparison fields: 5 of 159
- Pharmacology 2.4k
- Biochemistry 771
- Oncology 1.4k
- Hepatology 306
- Endocrinology, Diabetes and Metabolism 612
Countries citing papers authored by Michael T. Murray
This map shows the geographic impact of Michael T. Murray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael T. Murray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael T. Murray more than expected).
Fields of papers citing papers by Michael T. Murray
This network shows the impact of papers produced by Michael T. Murray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael T. Murray. The network helps show where Michael T. Murray may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael T. Murray, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 7 | |
| 6 | 2022 | 1 | |
| 7 | 2022 | 6 | |
| 8 | 2021 | 37 | |
| 9 | 2020 | 24 | |
| 10 | 2019 | 10 | |
| 11 | Pyrroloquinoline quinone (PQQ): the next essential nutrient and supplement superstar | 2018 | 1 |
| 12 | 2016 | 9 | |
| 13 | 2013 | 43 | |
| 14 | 2009 | 15 | |
| 15 | 1997 | 8 | |
| 16 | 1994 | 18 | |
| 17 | 1993 | 65 | |
| 18 | 1992 | 31 | |
| 19 | 1992 | 51 | |
| 20 | 1991 | 65 |
About Michael T. Murray
Michael T. Murray is a scholar working on Pharmacology, Biochemistry, Oncology, Endocrinology, Diabetes and Metabolism and Cancer Research, having authored 243 papers that have together received 6.3k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (107 papers), Eicosanoids and Hypertension Pharmacology (51 papers), Drug Transport and Resistance Mechanisms (50 papers), Hormonal Regulation and Hypertension (19 papers), Estrogen and related hormone effects (18 papers), Cancer, Hypoxia, and Metabolism (17 papers), Drug-Induced Hepatotoxicity and Protection (14 papers) and Inflammatory mediators and NSAID effects (13 papers). The work is most often cited by research in Pharmacology (2.4k citations), Biochemistry (771 citations), Oncology (1.4k citations), Hepatology (306 citations) and Endocrinology, Diabetes and Metabolism (612 citations). Michael T. Murray has collaborated with scholars based in Australia, United States and China. Frequent co-authors include Geoffrey C. Farrell, Gordon F. Reidy, Fanfan Zhou, Nenad Petrović, Alison Butler, Werner W. Franke, Tristan Rawling, Joseph E. Pizzorno, C.F. Wilkinson and Ling Zhu. Their work appears in journals such as Biochemical Pharmacology, British Journal of Pharmacology, Journal of Pharmacology and Experimental Therapeutics, Molecular Pharmacology and Xenobiotica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.